CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922160/ |